• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 97 of 100
Thiel, partner of Founders Fund, speaks during the panel discussion at the Milken Institute Global Conference in Beverly Hills, California
LeadershipPeter Thiel has never met a regulation he didn’t hate
By Ben GeierFebruary 10, 2015
161135392
FeaturesBiosimilars may one day save your life. But what are they?
By Laura LorenzettiFebruary 6, 2015
IL: Corporations In Illinois
FinanceFat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By Jen WiecznerFebruary 6, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FinancePfizer to acquire Hospira in a deal worth about $15 billion
By Fortune EditorsFebruary 5, 2015
Close-up of various intravenous solutions used during operations
FeaturesThere’s a national shortage of saline solution. Yeah, we’re talking salt water. Huh?
By Erika FryFebruary 5, 2015
Earns Pfizer
FeaturesIn speed mode, FDA approves Pfizer’s big new drug early
By Jen WiecznerFebruary 4, 2015
FDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
FinanceFDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
By Laura LorenzettiFebruary 4, 2015
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
FeaturesIs it time for the FDA to consider cost when it comes to new drugs?
By Laura LorenzettiFebruary 4, 2015
Inside of a Gilead Sciences Lab
TechBigger drug discounts put question mark over Gilead’s stellar run
By Reuters and Fortune EditorsFebruary 4, 2015
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
FinanceHow to save on your prescription meds (yep, there’s an app for that)
By Jean ChatzkyFebruary 3, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceAfter Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
Key Speakers At Osons La France Economic Summit
LeadershipFire in haste, repent at leisure: Sanofi wonders why it can’t find a new CEO
By ReutersJanuary 30, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FeaturesPfizer’s outlook disappoints as it struggles with patent expirations
By Laura LorenzettiJanuary 27, 2015
Regeneron vaults ahead of Amgen in race to market cholesterol drug
FeaturesRegeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
Negatively-stained Hong Kong Flu Virus
FeaturesOne shot to cure them all: The quest for the universal flu shot
By Erika FryJanuary 21, 2015
1...
  • 95
  • 96
  • 97
  • 98
  • 99
100
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.